In another airway hypersensitive state, recombined IL-37 (rIL-37) reduced airway inflammation and ameliorated asthma progression through suppressing thymic stromal lymphopoietin (TSLP) expression in lung tissues via inhibiting NF-κB and ERK1/2 pathways (72). This evidence concerns the gene IL37 and asthma.